Invention Grant
- Patent Title: mGluR5 modulators
- Patent Title (中): mGluR5调制剂
-
Application No.: US11902784Application Date: 2007-09-25
-
Publication No.: US07772235B2Publication Date: 2010-08-10
- Inventor: Methvin Isaac , Abdelmalik Slassi , Louise Edwards , Peter Dove , Tao Xin , Tomislav Stefanac
- Applicant: Methvin Isaac , Abdelmalik Slassi , Louise Edwards , Peter Dove , Tao Xin , Tomislav Stefanac
- Applicant Address: SE Sodertalje
- Assignee: Astrazeneca AB
- Current Assignee: Astrazeneca AB
- Current Assignee Address: SE Sodertalje
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Main IPC: A61K31/50
- IPC: A61K31/50 ; A61K31/44 ; C07D403/14 ; C07D413/14
Abstract:
The present invention is directed to compounds of formula I: Wherein R1 to R5, X and Z are further defined in the description. The invention also relates to processes for the preparation of the compounds and to intermediates used in the preparation, pharmaceutical compositions containing the compounds, and to the use of the compounds in therapy.
Public/Granted literature
- US20080125436A1 MgluR5 modulators Public/Granted day:2008-05-29
Information query
